Status:
COMPLETED
Integrating Multi-Omics Data for Enhanced Prognosis Prediction in Gastric Cancer Post-Neoadjuvant Therapy
Lead Sponsor:
Chang-Ming Huang, Prof.
Conditions:
Gastric Cancer (GC)
Eligibility:
All Genders
18+ years
Brief Summary
Study Protocol: Integrating Multi-Omics Data for Prognosis Prediction in Gastric Cancer Post-Neoadjuvant Therapy Objective: To develop and validate an integrative prognostic nomogram for patients wi...
Eligibility Criteria
Inclusion
- Gastric adenocarcinoma confirmed pathologically via gastroscopy;
- Clinical staging of cT3/T4N0/+M0 with a history of receiving at least two cycles of neoadjuvant therapy
- No prior history of other malignant tumors
- Completion of radical gastrectomy
Exclusion
- Gastric cancer originating from the remnant stomach
- Absence of baseline computed tomography (CT) data prior to treatment or suboptimal CT image quality that could compromise the accuracy of radiomic information extraction
- Absence of postoperative transcriptome data
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
179 Patients enrolled
Trial Details
Trial ID
NCT07190040
Start Date
January 1 2019
End Date
September 1 2025
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian Medical University
Fuzhou, Fujian, China, 350001